Upstream Bio, Inc. (UPB)
5.34
+0.03
(+0.56%)
USD |
NASDAQ |
Sep 18, 16:00
5.35
+0.01
(+0.19%)
After-Hours: 20:00
Upstream Bio Cash from Investing (Quarterly) : 15.76M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.76M |
| March 31, 2026 | 42.40M |
| December 31, 2025 | 58.94M |
| September 30, 2025 | 48.19M |
| Date | Value |
|---|---|
| June 30, 2025 | 12.77M |
| March 31, 2025 | -213.38M |
| December 31, 2024 | 41.91M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Sutro Biopharma, Inc. | 19.36M |
| Compass Therapeutics, Inc. | -4.977M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
| Anika Therapeutics, Inc. | -1.28M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -35.62M |
| Cash from Financing (Quarterly) | 2.533M |
| Free Cash Flow | -136.46M |
| Free Cash Flow Per Share (Quarterly) | -0.6528 |
| Free Cash Flow to Equity (Quarterly) | -35.46M |
| Free Cash Flow to Firm (Quarterly) | -35.62M |
| Free Cash Flow Yield | -47.09% |